Related Experiment Video
Updated: Aug 30, 2026
A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
Published on: June 14, 2015
Reducing the incidence and severity of pericardial adhesions with a sprayable polymeric matrix
Wolfgang F Konertz1, Martin Kostelka, Friedrich W Mohr
1Charité University Hospital for Cardiovascular Surgery, Berlin, Germany.
Insights
This study found that a polymeric agent significantly reduced pericardial adhesions after congenital heart surgery in infants. The antiadhesive treatment showed promising results with no adverse events, improving surgical outcomes.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Pediatric Cardiology
Background:
- Pericardial adhesions are a common complication following open-heart surgery in infants.
- These adhesions can complicate subsequent surgical procedures and impact patient outcomes.
- Developing effective antiadhesive strategies is crucial in pediatric cardiac surgery.
Purpose of the Study:
- To evaluate the antiadhesive properties of a novel polymeric agent.
- To assess the efficacy of the agent in preventing or reducing pericardial adhesions in infants undergoing staged surgical correction of congenital heart abnormalities.
Main Methods:
- A prospective study involving 16 infants undergoing staged surgical repair of congenital heart abnormalities.
- The polymeric agent was applied at the completion of the initial surgery.
- Five untreated infants served as controls, with adhesion tenacity and extent evaluated at follow-up surgery.
Main Results:
- The polymeric agent significantly reduced both the tenacity and extent of pericardial adhesions across multiple cardiac regions.
- Median tenacity scores favored the experimental treatment (1.0 vs 3.0, p < 0.01) at all sites combined.
- Adhesion extent scores also significantly favored the treatment (80 vs 270, p < 0.01), particularly at the right atrium and anterior great vessels.
Conclusions:
- The application of this polymeric agent after open cardiac surgery may effectively prevent or decrease the severity of pericardial adhesions.
- This antiadhesive strategy holds potential for improving outcomes in infants with congenital heart defects.
- No treatment-related adverse events were observed, suggesting a favorable safety profile.
Purpose:
This study was undertaken to evaluate the antiadhesive properties of a polymeric agent in infants undergoing staged surgical correction of congenital heart abnormalities.
Description:
Sixteen infants having staged surgical repair were treated with a polymeric matrix at the completion of the initial surgery. There were 5 untreated controls. The tenacity and extent of adhesions at five separate regions of the heart were evaluated at the follow-up surgery.
Evaluation:
For all sites combined, there was a threefold difference in median tenacity scores in favor of the experimental treatment (1.0 vs 3.0, p < 0.01). Significant differences were achieved separately at the right ventricle and the anterior surface of the great vessels (p = 0.02 for both comparisons). Analysis of adhesion scores reflecting the extent of adhesions similarly favored the experimental treatment for all sites (80 vs 270, p < 0.01), with significant differences persisting at the right atrium (p < 0.01) and the anterior surface of the great vessels (p = 0.04). There were no treatment-related adverse events.
Conclusions:
Use of this polymeric agent at the completion of open cardiac surgery may prevent the occurrence or reduce the severity of pericardial adhesions.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II